Forbes, D.; Thiessen, E.J.; Blake, C.M.; Forbes, S.C.; Forbes, S. Exercise programs for people with dementia.. The Cochrane database of systematic reviews. 2013-12-04, 12: CD006489. PMID 24302466. doi:10.1002/14651858.CD006489.pub3.
Burns, A; Iliffe, S. Dementia.. BMJ (Clinical research ed.). 2009-02-05, 338: b75. PMID 19196746.
Kavirajan, H.; Schneider, LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.. The Lancet. Neurology. September 2007, 6 (9): 782–92. PMID 17689146.
Commission de la transparence. Médicaments de la maladie d'Alzheimer : à éviter [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire Int. June 2012, 21 (128): 150. PMID 22822592.
Birks, J. Cholinesterase inhibitors for Alzheimer's disease.. The Cochrane database of systematic reviews. 2006-01-25, (1): CD005593. PMID 16437532.
Rolinski, M.; Fox, C.; Maidment, I.; McShane, R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.. The Cochrane database of systematic reviews. 2012-03-14, 3: CD006504. PMID 22419314.
Forbes, D.; Thiessen, E.J.; Blake, C.M.; Forbes, S.C.; Forbes, S. Exercise programs for people with dementia.. The Cochrane database of systematic reviews. 2013-12-04, 12: CD006489. PMID 24302466. doi:10.1002/14651858.CD006489.pub3.
Lozano, R; Naghavi, M; Foreman, K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.. Lancet. 2012-12-15, 380 (9859): 2095–128. PMID 23245604.